Rankings
▼
Calendar
LSTA Q4 2024 Earnings — Lisata Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
LSTA
Lisata Therapeutics, Inc.
$44M
Q4 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$1M
Gross Profit
$1M
100.0% margin
Operating Income
-$5M
-494.9% margin
Net Income
-$5M
-461.0% margin
EPS (Diluted)
$-0.55
QoQ Revenue Growth
+Infinity%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$871,763
Balance Sheet
Total Assets
$35M
Total Liabilities
$6M
Stockholders' Equity
$30M
Cash & Equivalents
$16M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$1M
$0
—
Gross Profit
$1M
$0
—
Operating Income
-$5M
-$6M
+17.9%
Net Income
-$5M
-$5M
+14.1%
← FY 2024
All Quarters
Q1 2025 →